NK521 in the Treatment of Advanced Solid Tumors

Clinical trial NCT07657416 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07657416
Sponsor: Base Therapeutics (Shanghai) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)Ovarian Cancer Malignant Ascites

Start date: 2026-06-01
Primary completion: 2027-10-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.